|Hope: Antibody-Mucus Interactions
|Prophylactic neutralizing Ab
|Study Start Date:
|Study Made Public:
Neutralization assay using the MUC5AC at constant concentration of (0.5mg/ml) and serial dilution of HIV-1 antibody panel.
CAVD 472 (MUC5AC) is an immunogenicity study to identify which antibodies respond to the presence of MUC5a/c, an oligomeric gel forming human mucin subtype.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.